methylprednisolone and Dysautonomia

methylprednisolone has been researched along with Dysautonomia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Kataria, S; Khan, E; Kramer, J; Moreno-Escobar, MC; Niaze, F; Peshwe, K; Sriwastava, S; Subedi, R; Tandon, M1
Finsterer, J1
Hunter, AJ; Ketterer, B; Montanaro, A1
Fabien, N; Hantson, P; Kevers, L; Van Den Bergh, P1

Reviews

1 review(s) available for methylprednisolone and Dysautonomia

ArticleYear
Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature.
    Journal of neuroimmunology, 2021, 04-15, Volume: 353

    Topics: Adult; Anti-Inflammatory Agents; Bromocriptine; COVID-19; Dopamine Agonists; Humans; Male; Methylprednisolone; Myelitis, Transverse; Primary Dysautonomias; SARS-CoV-2; Spinal Cord

2021

Other Studies

3 other study(ies) available for methylprednisolone and Dysautonomia

ArticleYear
Steroid-responsive, transverse myelitis is a known complication of COVID-19.
    Journal of neuroimmunology, 2021, 06-15, Volume: 355

    Topics: COVID-19; Humans; Methylprednisolone; Myelitis, Transverse; Primary Dysautonomias; SARS-CoV-2

2021
So Much More than Bald and Bloated.
    Journal of hospital medicine, 2018, 11-01, Volume: 13, Issue:12

    Topics: Abdominal Pain; Adult; Humans; Immunoglobulins; Immunologic Factors; Male; Methylprednisolone; Nausea; Plasmapheresis; Primary Dysautonomias; Rituximab

2018
Acute-onset chronic inflammatory demyelinating polyneuropathy with cranial nerve involvement, dysautonomia, respiratory failure, and autoantibodies.
    Muscle & nerve, 2010, Volume: 41, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; Cranial Nerve Diseases; Diagnosis, Differential; Disease-Free Survival; Electrodiagnosis; Female; Guillain-Barre Syndrome; Humans; Immunoglobulins, Intravenous; Lupus Erythematosus, Systemic; Methylprednisolone; Neural Conduction; Plasma Exchange; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Primary Dysautonomias; Quadriplegia; Respiration, Artificial; Respiratory Insufficiency; Treatment Outcome

2010